Deutsche Bank Aktiengesellschaft Begins Coverage on Axsome Therapeutics (NASDAQ:AXSM)
Deutsche Bank Aktiengesellschaft started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $176.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price target suggests a potential upside of 33.79% from the stock’s […]
Deutsche Bank Aktiengesellschaft started coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $176.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s price target suggests a potential upside of 33.79% from the stock’s […]
